<bill session="115" type="s" number="1960" updated="2019-10-18T16:07:58Z">
  <state datetime="2017-10-16">REFERRED</state>
  <status>
    <introduced datetime="2017-10-16"/>
  </status>
  <introduced datetime="2017-10-16"/>
  <titles>
    <title type="official" as="introduced">A bill to repeal the amendments made to the Controlled Substances Act by the Ensuring Patient Access and Effective Drug Enforcement Act of 2016.</title>
    <title type="display">A bill to repeal the amendments made to the Controlled Substances Act by the Ensuring Patient Access and Effective Drug Enforcement Act of 2016.</title>
  </titles>
  <sponsor bioguide_id="M001170"/>
  <cosponsors>
    <cosponsor bioguide_id="B001230" joined="2017-10-18"/>
    <cosponsor bioguide_id="C001070" joined="2017-10-19"/>
    <cosponsor bioguide_id="D000563" joined="2017-10-19"/>
    <cosponsor bioguide_id="G000555" joined="2017-10-18"/>
    <cosponsor bioguide_id="H001076" joined="2017-10-16"/>
    <cosponsor bioguide_id="K000367" joined="2017-10-17"/>
    <cosponsor bioguide_id="M001183" joined="2017-10-16"/>
    <cosponsor bioguide_id="M000133" joined="2017-10-24"/>
    <cosponsor bioguide_id="S001181" joined="2017-10-19"/>
  </cosponsors>
  <actions>
    <action datetime="2017-10-16">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2017-10-16" state="REFERRED">
      <text>Read twice and referred to the Committee on the Judiciary.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSJU" name="Senate Judiciary" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill type="h" session="115" relation="identical" number="4084"/>
  </relatedbills>
  <subjects>
    <term name="Crime and law enforcement"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Licensing and registrations"/>
    <term name="Prescription drugs"/>
    <term name="Retail and wholesale trades"/>
  </subjects>
  <amendments/>
  <summary date="2017-10-16T04:00:00Z" status="Introduced in Senate">This bill repeals two sections of the Ensuring Patient Access and Effective Drug Enforcement Act of 2016 and the amendments made by such sections to the Controlled Substances Act. The repealed sections modified registration and enforcement authorities of the Drug Enforcement Administration with respect to manufacturers, distributors, and dispensers of controlled substances.</summary>
  <committee-reports/>
</bill>
